Glial fibrillary acidic protein as a serum neuromarker of brain injury in pediatric patients with congenital heart defects undergoing cardiac surgery
Objective: The aim of this study was to assess glial fibrillary acidic protein (GFAP) as a marker of short-term neurodevelopmental delay in pediatric patients with congenital defects (CHD) after cardiovascular surgical intervention.
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-09-01
|
Series: | Acta Marisiensis - Seria Medica |
Subjects: | |
Online Access: | https://doi.org/10.2478/amma-2023-0037 |